Evaluating the Efficacy of Taurodeoxycholic Acid in Providing Otoprotection Using an in vitro Model of Electrode Insertion Trauma

Abstract

Cochlear implants (CIs) are widely used to provide auditory rehabilitation to individuals having severe to profound sensorineural hearing loss (SNHL). However, insertion of electrode leads to inner trauma and activation of inflammatory and apoptotic signaling cascades resulting in loss of residual hearing in implanted individuals. Pharmaceutical interventions that can target these signaling cascades hold great potential for preserving residual hearing by preventing sensory cell damage. Bile salts have shown efficacy in various regions of the body as powerful antioxidants and anti-inflammatory agents. However, their efficacy against inner ear trauma has never been explored. The objective of this study was to determine whether taurodeoxycholic acid (TDCA), a bile salt derivative, can prevent sensory cell damage employing an in vitro model of electrode insertion trauma (EIT). The organ of Corti (OC) explants were dissected from postnatal day 3 (P-3) rats and placed in serum-free media. Explants were divided into control and experimental groups: (1) untreated controls; (2) EIT; (3) EIT+ TDCA (different concentrations). Hair cell (HC) density, analyses of apoptosis pathway (cleaved caspase 3), levels of reactive oxygen species (ROS) as well as inducible nitric oxide synthase (iNOS) activity and Mitochondrial Membrane Potential (MMP) were assayed. Treatment with TDCA provided significant otoprotection against HC loss in a dose-dependent manner. The molecular mechanisms underlying otoprotection involved decreasing oxidative stress, lowering levels of iNOS, and abrogating generation of cleaved caspase 3. The results of the present study suggest that TDCA provides efficient otoprotection against EIT, in vitro and should be explored for developing pharmaceutical interventions to preserve residual hearing post-cochlear implantation.

Altered Blood Brain Barrier Permeability and Oxidative Stress in Cntnap2 Knockout Rat Model

“…The size and location of each ROI was consistent for all images. The mean signal intensity was measured and calculated using ImageJ version 1.52 k software (Bethesda, MD, USA) [ 68 ]. For quantification, the brain samples were weighted and homogenized.…”

“…The images were acquired using a confocal Zeiss Axiovert 700 microscope (Carl Zeiss Microimaging, LLC; Thornwood, New York, NY, USA). ImageJ version 1.52 k software (Bethesda, MD, USA) was used for processing and analyzing the images as well as for calculating the mean signal intensity as described for the FITC-Dextran assay [ 68 ].…”

Cellular and Molecular Targets for Non-Invasive, Non-Pharmacological Therapeutic/Rehabilitative Interventions in Acute Ischemic Stroke

“…HBO is a "therapeutic strategy" [7] aiming to raise the arterial oxygen tension and, thus, the oxygen supply to the tissues [84] via an increased plasma concentration in dissolved oxygen, ultimately driving the improved efficiency of cellular respiration and sustaining ATP synthesis [84], including in ischemic/hypoxic territories [52]. Progressively, HBO would ameliorate cerebral circulation, decrease brain edema, block inflammatory cascades [85] and neutrophil adhesion [86], alter the synthesis of cytokines by monocytes and increase the synthesis of heat shock proteins [87], and finally reduce the infarct size by mitigating cell death and restoring mitochondrial oxidative phosphorylation [7].…”

Current Concepts and Future Trends in Increasing the Benefits of Cochlear Implantation: A Narrative Review

“…When tested on normal hearing guinea pigs, the liposomal gel induced a hearing loss that remained constant until the following two weeks of the study [81]. These observations could restrict its medical use as a local protective agent during cochlear implantation and electrode insertion [82,83].…”

“…Animal studies [80][81][82][83] N-acetyl cysteine was protective against noise-induced cochlear damage and found to be safe to use; it was also found to be protective against electrode insertion trauma; in animal models, intracochlear N-ACC use resulted in signs of ossifiacation and hearing threshold increase, as well as hearing loss.…”